CDTs vs. Botanical Terpenes: Why the Source Matters

Walk into any cannabis extract operation and you'll hear the debate: botanical terpenes or cannabis-derived terpenes (CDTs)? On the surface, it seems like a cost question. Botanicals are dramatically cheaper. Lavender-derived linalool is linalool, right?

Not quite. The distinction matters enormously — to end consumers, regulators, and the premium market.

What Are Botanical Terpenes?

Botanical terpenes are extracted from non-cannabis plants — lavender, pine, citrus, hops — and blended to mimic cannabis profiles. Because the individual molecules are identical to those found in cannabis, they're technically accurate. A limonene molecule from a lemon is the same as limonene from a cannabis plant.

But cannabis produces hundreds of terpenes and unique aromatics simultaneously, many in trace amounts that no botanical blend can replicate. The ratio, the minor compounds, the way they interact — these create the nuance that experienced consumers recognize.

What Makes CDTs Different?

Cannabis-derived terpenes are extracted directly from the cannabis plant — ideally before cannabinoid extraction begins, while the terpene-rich compounds are still fully intact. This preserves:

• The full minor terpene profile unique to each strain
• The natural ratios that define a strain's character
• Trace sesquiterpenes and other volatiles absent in botanical blends

The result is a terpene isolate that is genuinely strain-specific — something no botanical blend can claim.

The Market Reality

Premium consumers increasingly know the difference and are willing to pay for it. CDTs command 3–10× the price of botanical terpenes at wholesale. For operators, that margin difference funds the cost of proper CDT extraction equipment many times over.

Regulatory pressure is also moving in one direction. Several markets are moving toward requiring accurate labeling of terpene sources. Botanical-blended products marketed as strain-specific face increasing scrutiny.

The Challenge: Capturing CDTs Without Losing Them

The problem with CDTs isn't demand — it's extraction. Terpenes are extremely volatile. Traditional cannabinoid extraction processes destroy them entirely. By the time a standard hydrocarbon or ethanol extraction is complete, the terpenes are gone.

This is the problem the STX-90 was built to solve: capture the terpene profile before cannabinoid extraction begins, using cryogenic technology that locks in volatiles rather than driving them off.